Evidence map›Paper›PMID 36388208›Full record

ArticleFrontiers in neurology2022

Critical COVID-19 disease: Clinical course and rehabilitation of neurological deficits.

Corinna Wimmer, Marion Egger, Jeannine Bergmann, Volker Huge, Friedemann Müller, Klaus Jahn

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Evidence of quality of life for hospitalised patients with COVID-19: a scoping review.Health technology assessment (Winchester, England) · 2024
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Corinna WimmerDepartment of Neurology and Intensive Care Medicine, Schoen Clinic Bad Aibling, Bad Aibling, Germany.
Marion EggerDepartment of Neurology and Intensive Care Medicine, Schoen Clinic Bad Aibling, Bad Aibling, Germany.
Jeannine BergmannDepartment of Neurology and Intensive Care Medicine, Schoen Clinic Bad Aibling, Bad Aibling, Germany.
Volker HugeDepartment of Neurology and Intensive Care Medicine, Schoen Clinic Bad Aibling, Bad Aibling, Germany.
Friedemann MüllerDepartment of Neurology and Intensive Care Medicine, Schoen Clinic Bad Aibling, Bad Aibling, Germany.
Klaus JahnDepartment of Neurology and Intensive Care Medicine, Schoen Clinic Bad Aibling, Bad Aibling, Germany.
Schön Klinik Bad Aibling · DELudwig-Maximilians-Universität München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The COVID-19 disease frequently causes neurological symptoms. Critically ill patients often require neurorehabilitation for manifestations like intensive care unit (ICU) acquired weakness or encephalopathy. The outcome of these patients, however, is largely unknown. Here we report the clinical course of critical affected COVID-19 patients from hospital admission to discharge from inpatient neurorehabilitation. Methods: Prospective cohort study. COVID-19 patients admitted to neurorehabilitation were included based on a laboratory-confirmed SARS-CoV-2 infection. Assessments [modified Rankin Scale (mRS), Barthel-Index, Fatigue-Severity-Scale-7 and health-related quality of life (EQ-5D-5L)] were conducted at admission and before discharge from inpatient care. Data were compared to the preclinical health status. Results: Sixty-one patients (62 ± 13 years, 16 female) were included in the analysis. Most patients had been treated on ICU ( Conclusion: Patients with neurological sequelae after critical COVID-19 disease showed substantial deficits at discharge from inpatient care up to 4 months after the initial infection. They were restricted in activities of daily living and had reduced health-related quality of life. All patients needed continued medical support and physical treatment.

Indexed as

COVID-19critical care outcomesneurological manifestationsneurological rehabilitationSARS-CoV-2

Identifiers

PMID36388208
PMCPMC9649895
OpenAlexW4307706022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.